“Through this we are working to standardise international lung cancer staging guidelines and are using this information to guide the development of the 9th edition of the Tumour, Node and ...

Positive phase 3 results from the CAN-2409 clinical trial in intermediate-to-high risk localized prostate cancer have been ...

HELSINKI, May 13, 2025 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (Tiltbio), a clinical-stage biotechnology company developing ...

The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...

Gastroesophageal reflux disease (GERD) is associated with a significant increase in the risk for lung cancer, according to study results presented at Digestive Disease Week (DDW), held May 3 to 6, ...

Low-dose computed tomography is more sensitive than chest radiography in diagnosing lung metastases of second primary lung cancer in HNSCC survivors.

The meta-analysis of 9 studies showed high sensitivity with slightly lower specificity with the less-invasive option for ...

Scientists at the Barcelona Institute for Global Health (ISGlobal) led the study, published Thursday in The Lancet ...

The findings could significantly change the ... Lung Cancer Test Predicts Survival in Early Stages Better Than Current Methods Jan. 9, 2025 — Researchers have shown that a test called ORACLE can ...

Apr. 7, 2025 — As many as one in 3,000 people could be carrying a faulty gene that significantly increases their risk of a punctured lung, according to new ... Apr. 2, 2025 — Lung cancer ...

The FDA granted accelerated approval to telisotuzumab vedotin (Emrelis) for the treatment of adults with previously treated, ...

Dr. John Lazar with Ascension Saint Thomas said the imaging agent known as Cytalux helps doctors see cancerous cells they may have missed. NASHVILLE, Tenn. (WTVF) — More than 225,000 Americans ...